Srivanichakorn, W., Sriwijitkamol, A., Kongchoo, A., Sriussadaporn, S., Plengvidhya, N., Lertwattanarak, R., . . . Thongtang, N. (2015). Withdrawal of sulfonylureas from patients with type 2 diabetes receiving long-term sulfonylurea and insulin combination therapy results in deterioration of glycemic control: A randomized controlled trial. Diabetes Metab Syndr Obes.
Citação norma ChicagoSrivanichakorn, Weerachai, Apiradee Sriwijitkamol, Aroon Kongchoo, Sutin Sriussadaporn, Nattachet Plengvidhya, Raweewan Lertwattanarak, Sathit Vannasaeng, and Nuntakorn Thongtang. "Withdrawal of Sulfonylureas From Patients With Type 2 Diabetes Receiving Long-term Sulfonylurea and Insulin Combination Therapy Results in Deterioration of Glycemic Control: A Randomized Controlled Trial." Diabetes Metab Syndr Obes 2015.
MLA引文Srivanichakorn, Weerachai, et al. "Withdrawal of Sulfonylureas From Patients With Type 2 Diabetes Receiving Long-term Sulfonylurea and Insulin Combination Therapy Results in Deterioration of Glycemic Control: A Randomized Controlled Trial." Diabetes Metab Syndr Obes 2015.